Pharming Group N.V. (PHAR) stock analysis

In our weekly check, Pharming Group N.V. is graded D (A to F). Of 24 checks on debt, profit, cash flow and trend: 10 pass, warnings: 6, red flags: 8.

Sector: Healthcare · Biotechnology

Strengths

• Low debt
• Profits backed by cash

Warning signs

• Weak interest cover
• Margins falling
• Thin margins
• Very volatile
• Thinly traded

Next earnings report: 2026-11-05

Similar companies

FDMT · ATTO · OLMA · WVE · MDXG · SLDB

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-10-10

Open the full analysis